True Wealth Design’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.29K Sell
79
-126
-61% -$2.36K ﹤0.01% 1844
2026
Q2
$3.09K Sell
205
-2
-1% -$35 ﹤0.01% 1528
2026
Q1
$3.97K Buy
207
+140
+209% +$3.04K ﹤0.01% 1290
2025
Q4
$1.47K Buy
67
+23
+52% +$415 ﹤0.01% 1565
2025
Q3
$535 Sell
44
-26
-37% -$352 ﹤0.01% 1990
2025
Q2
$1.3K Buy
70
+69
+6,900% +$1.37K ﹤0.01% 1357
2025
Q1
$20 Buy
+1
New +$29 ﹤0.01% 2587

Other funds holding TNDM

True Wealth Design's TNDM Position: Q3 2026 in Review

True Wealth Design reduced its Tandem Diabetes Care (TNDM) stake by 61% in Q3 2026, selling an estimated $2.36K and leaving 79 shares worth $1.29K. The position accounts for ﹤0.01% of the portfolio, ranked #1844.

True Wealth Design first reported a position in TNDM in Q1 2025 and has held it in 7 quarters since. The position peaked at $3.97K in Q1 2026. 15 funds tracked by Wall St. Rank hold TNDM as of Q3 2026.

  • True Wealth Design held 79 shares of Tandem Diabetes Care worth $1.29K as of Q3 2026.
  • True Wealth Design sold 126 Tandem Diabetes Care shares in Q3 2026, an estimated $2.36K.
  • Tandem Diabetes Care made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #1844 holding.
  • True Wealth Design first reported a position in Tandem Diabetes Care in Q1 2025 and has held it in 7 quarters since.
  • True Wealth Design's Tandem Diabetes Care position peaked at $3.97K in Q1 2026.
  • 15 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.